• Our Members
  • Events
  • Contact us
AMR Industry Alliance
  • About us
    • Why the AMR Industry Alliance?
    • Board Members
  • Shared Goals
    • AMR Industry Declaration
    • Industry Roadmap for Progress on Combating Antimicrobial Resistance
    • Responsible Manufacturing
  • Why AMR?
  • Newsroom
  • Progress Report
  • In Action
Select Page
CENTRIENT AND CIPLA COMBAT IRRATIONAL ANTIBIOTIC USE IN CHINA AND INDIA

CENTRIENT AND CIPLA COMBAT IRRATIONAL ANTIBIOTIC USE IN CHINA AND INDIA

by Morgane De Pol | Feb 10, 2020

BACT’ATTACK®

BACT’ATTACK®

by Morgane De Pol | Apr 16, 2018

Pfizer, ICMR to Establish a Centre in New Delhi to Combat AMR

by Morgane De Pol | Mar 7, 2018

Abbott (formerly Alere) – Test Target Treat™

Abbott (formerly Alere) – Test Target Treat™

by mcwebmaster | Dec 22, 2017

SIRTURO® (bedaquiline) Development and Launch

SIRTURO® (bedaquiline) Development and Launch

by mcwebmaster | Dec 21, 2017

« Older Entries

stay informed

Subscribe to receive our updates

about us

The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.

read more
contact

AMR Industry Alliance Secretariat (IFPMA)
Chemin des Mines 9
P.O. Box 195
1211 Geneva 20
Switzerland
Email: info@amrindustryalliance.org

© AMR Industry Alliance 2017 - Contact us - Cookies Policy - Privacy Policy - Terms of use - Privacy Centre - Careers